Zealand Pharma A/S (ZEAL) — Cash Flow Quality Index
Zealand Pharma A/S (ZEAL) has a Cash Flow Quality Index of 1.12x as of June 2025. Operating cash flow of Dkr8.52 Billion exceeds net income of Dkr7.57 Billion, indicating high earnings quality where cash backs reported profits. Explore long-term investment intensity of Zealand Pharma A/S to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Zealand Pharma A/S Cash Flow Quality Index (2011–2025)
Historical Cash Flow Quality Index for Zealand Pharma A/S across 4 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check ZEAL intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Zealand Pharma A/S (2011–2025)
Year-by-year earnings quality comparison for Zealand Pharma A/S. For live market cap and the full company financial profile, see Zealand Pharma A/S (ZEAL) market capitalisation.
| Year | Quality Index | Operating CF (DKK) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.01x | Dkr6.53 Billion | Dkr6.46 Billion | ▲ +227.8% |
| 2018 | -0.79x | Dkr-460.40 Million | Dkr581.28 Million | ▼ -142.0% |
| 2012 | 1.88x | Dkr68.54 Million | Dkr36.37 Million | ▲ +1495.7% |
| 2011 | -0.14x | Dkr-1.81 Million | Dkr13.38 Million | — |